About YanengBIO
Leading the Molecular Diagnostics Market in China for 22 years.
Since 2001, Yaneng BIOscience (Shenzhen) Co., Ltd. developed the first gene chip in China, YanengBIO has taken the leading position in the Molecular diagnostics market in China through 22 years of development and continuous innovation. YanengBIO have established the leading position in the Molecular diagnostics market in China. At present, the company has about 600 employees, among which the R&D department led by Ph.D team accounts for more than 20%.
At present, our core products, HPV and Thalassemia projects, have occupied No.1 place in the Chinese market, with sales revenue CAGR of 24% and annual R&D expenditure 18%.
100000000
HPV Product testing
22000000
Thalassemia gene product testing
100000000
MNP product testing
Data as of 4 November 2024
